NIH Common Fund Initiatives

NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) (RFA-RM-20-011)

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-011.html

Purpose

The NIH Pioneer Award initiative complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose pioneering and possibly transforming approaches to addressing major biomedical or behavioral challenges that have the potential to produce an unusually high impact on a broad area of biomedical or behavioral research. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator’s research program or elsewhere.

Deadlines

Deadlines for application – September 11, 2020 by 5:00 PM local time of applicant organization.
This programs expires on September 12, 2020.

NIH Director's New Innovator Award Program (DP2 Clinical Trial Optional) (RFA-RM-20-012)

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-012.html

Purpose

The NIH Director’s New Innovator (DP2) Award initiative supports a small number of early stage investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research. The New Innovator Award initiative complements ongoing efforts by NIH and its Institutes and Centers to fund early stage investigators through R01 grants, which continue to be the major sources of NIH support for early stage investigators. The NIH Director’s New Innovator Award initiative is a component of the High Risk - High Reward Research Program of the NIH Common Fund.

Deadlines

Deadlines for application – August 21, 2020 by 5:00 PM local time of applicant organization.
This program expires on August 22, 2020.

NIH Directors Transformative Research Award (R01 - Clinical Trial Optional) (RFA-RM-20-013)

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-013.html

Purpose

The NIH Transformative Research Awards complements NIH’s traditional, investigator-initiated grant programs by supporting individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Little or no preliminary data are expected. Projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research.

Deadlines

Deadline for application – September 30, 2020, by 5:00 PM local time of applicant organization.
This program expires on October 1, 2020.

NIH Directors Early Independence Award (DP5 Clinical Trial Optional) (RFA-RM-20-014)

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-014.html

Purpose

The NIH Director’s Early Independence Award Program supports exceptional investigators who wish to pursue independent research directly after completion of their terminal doctoral/research degree or clinical residency, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career.

Deadlines

Deadline for application – September 4, 2020, by 5:00 PM local time of applicant organization.
This program expires on September 5, 2020.

 

The following two (2) FOAs solicit applications responsive only to the COVID-19 public health emergency through support of the CARES Act. All other Transformative Research or Early Independence Award applications must be submitted in response to RFA-RM-20-013 or RFA-RM-20-014. 

NIH Directors Emergency Transformative Research Award (R01 - Clinical Trial Optional) (RFA-RM-20-020)

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-020.html

Purpose

The NIH Transformative Research Awards complements NIH’s traditional, investigator-initiated grant programs by supporting individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Little or no preliminary data are expected. Projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research.

Deadlines

Deadline for application – September 30, 2020, by 5:00 PM local time of applicant organization.
This program expires on October 1, 2020.

NIH Directors Emergency Early Independence Award (DP5 Clinical Trial Optional) (RFA-RM-20-021)

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-021.html

Purpose

The NIH Director’s Emergency Early Independence Award Program supports exceptional investigators who wish to pursue independent research directly after completion of their terminal doctoral/research degree or clinical residency, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career.

Deadlines

Deadline for application – September 4, 2020, by 5:00 PM local time of applicant organization.
This program expires on September 5, 2020.

 

NLM Contact

Dr. Hua-Chuan Sim, simh@mail.nlm.nih.gov.

Helper Links for Common Fund Initiatives 

NIH Common Fund Web Site

Grant Program Overview

Research Support
Resource Support
Career Support
Training Support
Small Business R & D Support